HomeELVN • NASDAQ
add
Enliven Therapeutics Inc
Previous close
$18.30
Day range
$17.46 - $18.40
Year range
$13.30 - $30.01
Market cap
892.37M USD
Avg Volume
317.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 26.90M | 25.51% |
Net income | -23.18M | -19.67% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -26.82M | -25.60% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 313.44M | 23.82% |
Total assets | 325.76M | 19.82% |
Total liabilities | 15.92M | -38.70% |
Total equity | 309.84M | — |
Shares outstanding | 49.00M | — |
Price to book | 2.89 | — |
Return on assets | -21.31% | — |
Return on capital | -22.48% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -23.18M | -19.67% |
Cash from operations | -17.20M | -37.82% |
Cash from investing | 727.00K | -98.12% |
Cash from financing | 39.97M | 44,313.33% |
Net change in cash | 23.50M | -10.64% |
Free cash flow | -11.94M | -175.41% |
About
Founded
2016
Headquarters
Website
Employees
62
